Zdrowie i gospodarka · 06/07/2026

FDA Corrects Notice on Expedited Investigational New Drug Pilot Program

The Food and Drug Administration (FDA) is revising a public notice to gather feedback on a proposal to accelerate the development of new drugs, aiming to reduce the time between drug discovery and human clinical trials while safeguarding the rights of trial participants.